⭐ 2021 Most viewed @FrontOncology papers in #SkinCancer ⭐ #7: Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant #Melanoma in the Post Interferon-Alpha Era 👩⚕️👨⚕️ Konstantinos Christofyllakis et al. 📄 https://t.co/fzdlYa5m0q @Saar_Uni #SKCsm #O
RT @FrontOncology: New research: Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Syste…
New research: Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis: Introduction Multiple agents are approved in the adjuvant setting of completely resected… https://t.co/o